AMALGAMATED BANK - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$712,000
+126.0%
10,450
+5.9%
0.01%
+133.3%
Q2 2022$315,000
-10.0%
9,871
-2.3%
0.00%0.0%
Q1 2022$350,000
-44.6%
10,100
-53.2%
0.00%
+50.0%
Q4 2021$632,000
+133.2%
21,576
+102.7%
0.00%0.0%
Q3 2021$271,000
-31.6%
10,646
-5.8%
0.00%
-33.3%
Q2 2021$396,000
-12.0%
11,302
+2.4%
0.00%
-82.4%
Q1 2021$450,000
-13.5%
11,039
-8.0%
0.02%
-15.0%
Q4 2020$520,000
-20.4%
11,998
+1.3%
0.02%
-28.6%
Q3 2020$653,000
-14.8%
11,840
-2.5%
0.03%
-20.0%
Q2 2020$766,000
+44.8%
12,138
+17.2%
0.04%
+169.2%
Q1 2020$529,000
-37.8%
10,355
-3.1%
0.01%
-18.8%
Q4 2019$850,000
+81.6%
10,690
+10.7%
0.02%
+60.0%
Q3 2019$468,000
-8.9%
9,655
-1.2%
0.01%
-16.7%
Q2 2019$514,000
+21.8%
9,772
+22.6%
0.01%
+20.0%
Q1 2019$422,000
+40.7%
7,968
+8.9%
0.01%
+11.1%
Q4 2018$300,000
-13.0%
7,320
-4.0%
0.01%
+12.5%
Q2 2018$345,000
+37.5%
7,624
+46.5%
0.01%
+14.3%
Q1 2018$251,0005,2040.01%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders